News
30-05-2023
Pre-launch in Saudi Arabia
Exciting news: in Saudi Arabia the first pre-launch training activities started this month. We are looking forward to the product registration and the launch of iVAC 2L –…
26-04-2023
Poland Warsaw Course on Cardiovascular Interventions
WCCI, or Warsaw Course on Cardiovascular Interventions , is one of the most important conferences organized in Warsaw under the auspices of the Association of Cardiovascular Interventions (AISN)…
08-03-2023
Announcement Center of Excellence in Dubai
We are proud to announce the AL QASSIMI HOSPITAL, Sharjah, Dr Arif Al Nooryani, Chief Executive Officer & Head of Cardiac Centre for being appointed as Center of…
16-02-2023
“30 Most Valuable Brands of the Year 2022”
PulseCath BV is listed by Silicon Review under “30 Most Valuable Brands of the Year 2022″. We are really honoured and proud to be part of this. Thank…
09-02-2023
Germany NUB status 1 reimbursement iVAC 2L
Great achievement in Germany: NUB status 1 reimbursement for iVAC 2L in Germany again, with a record of #300 hospitals! Especially during these uncertain times, this is another significant support…
07-02-2023
Italy JIM-GISE congress 8-11 February 2023
💡 Together with our partner EUKON S.r.l.e. we are exhibiting JIM-GISE Interventional Cardiology Congress on 9-11 February, 2023 at Rosa Grand Hotel in Milan including a dynamic Fellows Course on 8…
07-02-2023
Product launch in Malaysia
Another milestone reached. We are proud to announce the achievement of product registration for iVAC 2L in Malaysia. The first 2 successful iVAC 2L cases were performed at…
07-02-2023
GHP Technology award
⚡️GHP Magazine Announces the Winners of the 2022 Technology Awards⚡️ Global Health & Pharma Magazine (GHP) awarded PulseCath with the Technology Awards for Best Heart Failure Pumping Functions…
30-11-2022
Congress CSI FOCUS D-HF Frankfurt, December 9-10, 2022
PulseCath is proud sponsor at CSI FOCUS D-HF, December 9-10, 2022 in Frankfurt. Want to learn more about iVAC 2L, pulsatile percutaneous ventricular assist device, for protected high-risk…
27-11-2022
Regretful notification that Dr. Yoram Karmon, PhD- CEO & President has died
It is with deep sadness that we inform you about the passing of Dr. Yoram Karmon, PhD- CEO & President.Dr. Yoram Karmon passed away unexpectedly by a septic…
